Document is current
Any future updates will be listed below
-
Authors
Mendes-Bastos, Pedro https://orcid.org/0000-0002-2439-920X
Lobo, Inês
Pires da Rosa, Gilberto
Pimenta, Rita
Gonçalo, Margarida
,
Brasileiro, Ana
Figueiredo, Ana Carolina
Lencastre, André
Roda, Ângela
Roque Ferreira, Bárbara
Duarte, Bruno
Queirós, Catarina
Amaro, Cristina
Mota, Fernando
Antunes, Joana
Reis, Joel
Ramos, Leonor
Rato, Margarida
Cruz, Maria João
Henrique, Martinha
Preto Gomes, Nuno
Varela, Paulo
Medeiros, Sandra
-
Funding
Funding for this research was provided by:
Sociedade Portuguesa de Dermatologia e Venereologia
Sanofi
Galderma
- License Information
-
More Information
Article History
Received: 6 March 2026
Accepted: 9 April 2026
First Online: 18 May 2026
Declarations
:
: Gilberto Pires da Rocha has received honoraria for acting as a speaker for Leo-Pharma, Sanofi, and L’Oreal. Inês Lobo participated in advisory boards and/or speakers bureau from AbbVie, Novartis, Beiersdorf. Inês Lobo has served as principal investigator in clinical trials and/or observational studies supported by AbbVie, Sanofi, Novartis and MoonLake Immunotherapeutics. Margarida Gonçalo participated in advisory boards and/or speakers bureau from AbbVie, Almirall, Astrazeneca, Biocryst, Leo-Pharma, Novartis, Pfizer, Sanofi-Genzyme, and Takeda. Pedro Mendes-Bastos has received honoraria for acting as a consultant and/or as a speaker for Almirall, Alumis, Apogee, AbbVie, Pfizer, Johnson & Johnson Innovative Medicine, Leo-Pharma, GlaxoSmithKline, Novartis, Eli Lilly, Sanofi, Regeneron, L’Oreal, Pierre Fabre, Viatris, Organon, Evelo Biosciences, CS Labs, and Takeda; Pedro Mendes-Bastos has served as principal investigator in clinical trials supported by AbbVie, Alumis, Amgen, Biogen, Johnson & Johnson Innovative Medicine, Pfizer, Novartis, Sanofi, and Sanofi-Regeneron. Rita Pimenta has received honoraria for acting as a consultant and/or speaker for AbbVie, Almirall, Leo-Pharma, LETI Pharma, and Novartis and served as principal investigator in clinical trials and/or observational studies supported by AbbVie, Almirall, Johnson & Johnson Innovative Medicine, and Novartis.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors. The Delphi panel reflects only the opinions of participating experts who voluntarily completed the questionnaire. Consequently, ethical review or formal approval was not required. Participation in the Delphi panel was entirely voluntary and fully anonymized, and all participants provided informed consent regarding the handling and protection of their personal data prior to participation.
